ACHV
Achieve Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$7.98
+0.88%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 75.83x
- P/S forward
- 20.84x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -55.95x
- Price / sales
- —
- Price / cash flow
- -17.47x
Enterprise value
- Enterprise value
- $648.8M
- EV / sales
- —
- EV / EBITDA
- -5.75x
- EV / EBIT
- -11.13x
- Market cap
- $821.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026